The prognostic value of biological markers in paediatric Hodgkin lymphoma
European Journal of Cancer2015Vol. 52, pp. 33–40
Citations Over TimeTop 16% of 2015 papers
Piero Farruggia, Giuseppe Puccio, Alessandra Sala, Alessandra Todesco, Salvatore Buffardi, Alberto Garaventa, Gaetano Bottigliero, Maurizio Bianchi, Marco Zecca, Franco Locatelli, Andrea Pession, Marta Pillon, Claudio Favre, Salvatore D’Amico, Massimo Provenzi, Angela Trizzino, Giulio Andrea Zanazzo, Antonella Sau, Nicola Santoro, G Murgia, Tommaso Casini, Maurizio Mascarin, Roberta Burnelli, Simone Cesaro, Ada Zaccaron, Patrizia Bertolini, Caterina Consarino, Grazia Iaria, Roberta Pericoli, Paolo Pierani, Fausto Fedeli, Monica Cellini, Raffaela De Santis, Fulvio Porta, Mauro Caini, Carlo Cosmi, Nadia Mirra, Adele Civino, Domenico Sperlì, Luigi Nespoli, Maurizio Caniglia, Katia Perruccio, Paolo D’Angelo, Eva Passone, Roberta Caruso, Giovanni Scarzello, Roberto Rondelli
Related Papers
- ABVD in the treatment of Hodgkin's disease.(1992)
- → Early Intensification Treatment Approach in Advanced-stage Hodgkin Lymphoma(2013)5 cited
- → Hodgkin's disease with leptomeningeal involvement: Report of a case with long survival(1984)20 cited
- Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.(1984)
- [Tolerance and results of treatment of Hodgkin's disease].(1995)